NEW YORK, August 22, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Urban Outfitters Inc. (NASDAQ: URBN), Costco Wholesale Corporation (NASDAQ: COST), Trinity Industries Inc. (NYSE: TRN), CVS Caremark Corporation (NYSE: CVS) and The Gap, Inc. (NYSE: GPS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5914-100free.

-- Urban Outfitters Inc. Research Reports

On August 18, 2014, Urban Outfitters Inc. (Urban Outfitters) announced its Q2 FY 2015 and H1 FY 2014 financial results (period ended July 31, 2014). For Q2 FY 2015, total sales were $811.3 million, up 7.0% YoY. During the quarter, the contribution of retail segment in total sales declined to 92.7% from 94.3% in Q2 FY 2014. In terms of net sales by brand, Anthropologie Group accounted for 42.9% of the total net sales, followed by Urban Outfitters made up 40.5% of net sales during the quarter. Net income was at $67.5 million or $0.49 per diluted share compared with $76.4 million or $0.51 per diluted share in Q2 FY 2014. For H1 FY 2015, total sales were $1.5 billion, up 6.5% YoY. Net income was reported at $105.0 million or $0.74 per diluted share versus $123.4 million or $0.83 per diluted share in Q2 FY 2014. Richard A. Hayne, CEO said, "We are pleased to announce record second quarter sales driven by strong performances at our Anthropologie and Free People brands. This achievement is a testament to the strength and validity of our model and to the ability of our talented teams to create powerful lifestyle brands, through compelling product, imagery and experiences." The full research reports on Urban Outfitters are available to download free of charge at:

http://www.analystsreview.com/Aug-22-2014/URBN/report.pdf

-- Costco Wholesale Corporation Research Reports

As per the Events Calendar of Costco Wholesale Corporation (Costco), the Company is scheduled to release its August 2014 sales results on September 4, 2014. The full research reports on Costco are available to download free of charge at:

http://www.analystsreview.com/Aug-22-2014/COST/report.pdf

-- Trinity Industries Inc. Research Reports

On August 18, 2014, Trinity Industries Inc. (Trinity) announced that the Company has completed the acquisition of Meyer Steel Structures (Meyer), as previously announced in its press release dated June 27, 2014. According to Company, the purchase price before transaction fees was c.$600 million. Trinity informed that it will report its revenue from Meyer within its Energy Equipment Group starting with Q3 2014 financial results. Timothy R. Wallace, Trinity's Chairman, CEO, and President, stated, "Meyer's strong engineering reputation, manufacturing capabilities, and products with high steel content align well with Trinity's existing competencies and offer opportunities to create additional value. The acquisition broadens Trinity's product portfolio, aligns with our strategy of growing our presence in the energy and infrastructure markets, and supports our vision of being a premier, diversified industrial company." The full research reports on Trinity are available to download free of charge at:

http://www.analystsreview.com/Aug-22-2014/TRN/report.pdf

-- CVS Caremark Corporation Research Reports

On August 18, 2014, CVS Caremark Corporation (CVS Caremark) announced that its Accordant Health Services division has obtained a full NCQA Patient and Practitioner Oriented Disease Management (DM) accreditation for programs to support a list of chronic diseases such as: Epilepsy (Seizures), Rheumatoid Arthritis, Multiple Sclerosis, Crohn's Disease, Ulcerative Colitis, Parkinson's Disease, Systemic Lupus Erythematosus (SLE or Lupus), Myasthenia Gravis, Sickle Cell Disease, Cystic Fibrosis amongst others. The Company stated that Accordant's DM accreditation program is based on the benchmark it has set in the following areas such as: Evidence-Based Program; Patient Service; Practitioner Service; Care Coordination; Measurement and Quality Improvement; and Program Operations. Trip Hofer, President, Accordant Health Services, said, "Earning NCQA accreditation provides our clients with further assurance as to the quality of our care management programs for rare and complex conditions." The full research reports on CVS Caremark are available to download free of charge at:

http://www.analystsreview.com/Aug-22-2014/CVS/report.pdf

-- The Gap, Inc. Research Reports

On August 19, 2014, The Gap, Inc. (Gap) announced its new fall campaign, which celebrates the notion of individuality and genuineness of personal style by questioning what it means to Dress Normal. According to the Company, the Campaign, which features photography of celebrities, known for their own art of dressing normal, starts with its print ads in August 2014 in countries such as United States, Canada, United Kingdom, France, Italy and Japan and few other selected regions. Gap informed that the campaign will be fully launched on September 2, 2014 globally across different media. Further, in mid-September, the Company will launch the Dress Normal Project to the said campaign. Gap informed that the project will feature people from North America talking about what dressing normal means to them. The full research reports on Gap are available to download free of charge at:

http://www.analystsreview.com/Aug-22-2014/GPS/report.pdf

-- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

=============== EDITOR'S NOTES: ===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Analysts Review